Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Daiichi Sankyo
Farmers Insurance
AstraZeneca
Colorcon
QuintilesIMS

Generated: August 17, 2019

DrugPatentWatch Database Preview

CITALOPRAM HYDROBROMIDE Drug Profile

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Which patents cover Citalopram Hydrobromide, and when can generic versions of Citalopram Hydrobromide launch?

Citalopram Hydrobromide is a drug marketed by Mylan Pharms Inc, Aurobindo Pharma Ltd, Hetero Labs Ltd Iii, Lannett Co Inc, Pd Partners, West-ward Pharms Int, Biovail Labs Intl, Acp Nimble, Amneal Pharms Ny, Apotex Inc, Aurobindo, Chartwell Molecular, Dr Reddys Labs Ltd, Epic Pharma, Epic Pharma Llc, Fosun Pharma, Glenmark Generics, Heritage Pharma, Invagen Pharms, Jubilant Generics, Mylan, Natco Pharma Ltd, Roxane, Sun Pharm Inds Inc, Sun Pharm Industries, Taro, Torpharm, and Torrent Pharms. and is included in thirty-three NDAs.

The generic ingredient in CITALOPRAM HYDROBROMIDE is citalopram hydrobromide. There are fifty-six drug master file entries for this compound. Sixty-eight suppliers are listed for this compound. Additional details are available on the citalopram hydrobromide profile page.

Drug patent expirations by year for CITALOPRAM HYDROBROMIDE
Pharmacology for CITALOPRAM HYDROBROMIDE
Medical Subject Heading (MeSH) Categories for CITALOPRAM HYDROBROMIDE
Synonyms for CITALOPRAM HYDROBROMIDE
(S)-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile hydrobromide
1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile hydrobromide
1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile monohydrobromide
1-(3-(dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile monohydrobromide
1-(3-(Dimethylamino)propyl)-1,-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile monohydrobromide
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile hydrobromide
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile
1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile hydrobromide
1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile Hydrobromide
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile hydrobromide
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile;hydrobromide
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-isobenzofuran-5-carbonitrile hydrobromide
4CH-017662
5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-, monohydrobromide
5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-,monohydrobromide
59729-32-7
729C327
A832439
AB0107058
AB1010898
AB10921
AC-1595
AC1L2U9E
AK-72795
AKOS005145738
AN-14765
ANW-42935
Apertia
API0006328
ARK092
AX8121801
BC207875
BCP9000537
BG0143
Bonitrile HBr
BR-72795
C 7861
C20H21FN2O.HBr
CCG-101022
CCG-213271
Celexa
Celexa (TN)
CHEMBL1200781
Cipramil
Citalopram (hydrobromide)
Citalopram for system suitability, European Pharmacopoeia (EP) Reference Standard
Citalopram HBr
Citalopram hydrobromide (USAN)
Citalopram hydrobromide [USAN:USP]
Citalopram hydrobromide [USAN]
Citalopram Hydrobromide 0.1 mg/ml in Methanol (as free base)
Citalopram Hydrobromide 1.0 mg/ml in Methanol (as free base)
Citalopram hydrobromide solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material
Citalopram hydrobromide solution, 100 mug/mL in methanol (as free base), ampule of 1 mL, certified reference material
Citalopram hydrobromide, >=98% (HPLC)
Citalopram hydrobromide, European Pharmacopoeia (EP) Reference Standard
Citalopram Hydrobromide, Pharmaceutical Secondary Standard; Certified Reference Material
Citalopram hydrobromide, United States Pharmacopeia (USP) Reference Standard
CITALOPRAM, HYDROBROMIDE SALT
CPD000326936
CS-4735
CTK8B3679
D00822
DTXSID40872344
EINECS 261-890-6
Elopram
EU-0100258
FT-0600173
HSDB 7042
HY-B1287
I06-0616
J10477
KS-00000FXR
KS-1043
LP00258
LS-84329
Lu 10-171 HBr
Lu 10-171-B
Lu-10-171B
LU-10171B
Lupram
MFCD02101306
MLS000758293
MLS000860078
MLS001401376
MLS002222294
MolPort-003-940-770
NC00272
NCGC00093717-01
NCGC00093717-02
NCGC00093717-03
NCGC00260943-01
Nitalapram HBr
NSC-758684
NSC758684
Pharmakon1600-01504172
Prepram HBr
Prisdal
Q-200865
recital hydrobromide
RP17855
s4749
SAM001246599
SAM001247086
SC-18021
SCHEMBL1118
Sepram
Seropram
SMR000326936
SR-01000003129
SR-01000003129-10
SR-01000003129-2
SR-01000003129-4
ST2403129
TL8003797
Tox21_500258
TR-020691
W-105304
WIHMBLDNRMIGDW-UHFFFAOYSA-N
Z1550648760
ZD 211; LU 10-171
ZD-211

US Patents and Regulatory Information for CITALOPRAM HYDROBROMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roxane CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077041-001 Nov 23, 2004 DISCN No No   Try a Free Trial   Try a Free Trial   Try a Free Trial
Glenmark Generics CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077654-002 Feb 27, 2009 AB RX No No   Try a Free Trial   Try a Free Trial   Try a Free Trial
Epic Pharma Llc CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077036-002 Oct 28, 2004 DISCN No No   Try a Free Trial   Try a Free Trial   Try a Free Trial
Torrent Pharms CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 078216-001 Mar 27, 2007 AB RX No No   Try a Free Trial   Try a Free Trial   Try a Free Trial
Heritage Pharma CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077213-002 Mar 31, 2006 DISCN No No   Try a Free Trial   Try a Free Trial   Try a Free Trial
Jubilant Generics CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 205407-003 Dec 23, 2015 AB RX No No   Try a Free Trial   Try a Free Trial   Try a Free Trial
Heritage Pharma CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077213-001 Mar 31, 2006 DISCN No No   Try a Free Trial   Try a Free Trial   Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Baxter
Cantor Fitzgerald
Cipla
Covington
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.